Table of Contents

Evidence that chronic disease is caused by pathogens

The mainstream, but antiquated, view about chronic disease is best expressed by a certain physician thusly: “Of our thousand bacterial species, I only have to worry about a couple dozen” while a 2002 Nature paper concludes, “Multicellular organisms live, by and large, harmoniously with microbes.1)

However, there is substantial evidence that chronic diseases are caused by pathogens as opposed to other causes. This evidence includes:

In addition, it seems highly likely that supposedly non-infectious chronic diseases are in fact caused by pathogens when one considers their clinical features, histology, treatment response, microbe populations, presence of co-infections, the ease with which co-infections proliferate, and the failure of systematic lifestyle interventions.

According to the Marshall Pathogenesis, humans accumulate a plethora of pathogenic bacteria during their lifetimes, and it is the genetic mutations which result from active infection that play a major role in what is commonly thought of as “genetic susceptibility.”

Besides the absence of proof implicating human genes as the major causative factor, there is a range of evidence - including strong epidemiological and compelling evolutionary evidence - suggesting that pathogens cause chronic diseases.

Epidemiological evidence

Epidemiological evidence including case clustering in time or location supports a pathogenic cause for disease.

Other evidence

There is also the following types of evidence, the first three of which are noted in a 1998 article and 200527) paper by David Relman and David Fredricks:

Newer cultivation techniques have associated bacterial count in a pregnant woman's amniotic fluid with age at delivery. This data strongly suggests a causative role for pathogenic bacteria in premature delivery. Source: DiGulio et al.

Evolutionary evidence

One useful way to determine if a disease is caused by faulty human genes is look towards the central principle of evolutionary biology: evolutionary fitness. Evolutionary fitness is defined as the extent to which an organism is adapted to or able to produce offspring in a particular environment. The fitness concept can be applied to the problem of disease causation to distinguish evolutionarily feasible hypotheses of causation from marginally feasible or untenable ones.52) 53)

If the common inflammatory diseases (including autoimmune diseases) were genetic, the only way they would manage not to be weeded out of the population would be if they conferred some sort of beneficial survival trait not related to the disease.

To date, no such benefits have been identified in any chronic disease, schizophrenia being a good example.54) Schizophrenics have a high suicide rate, few children, and a high rate of abnormality in their children.55) 56) Schizophrenic mothers are more likely than non-schizophrenics to have stillborn babies and children with congenital malformations.57) This would mean schizophrenic mothers and fathers would be less likely to pass on a theoretical schizophrenic gene to their offspring. On the contrary, incidence of the disease is only escalating suggesting that bacteria are passed from generation to generation.

Motive and opportunity

Biology and law typically don't have much in common, but one useful metaphor for considering the validity of a proposed pathogenesis for chronic disease is to compare the search for the cause of disease to that of a trial for homicide. Two key pieces of evidence in any such trial are opportunity and motive. Basically, could the defendant have done it, and was it in his interests to do so?

Bacteria have both motive and opportunity.

Unlike toxins, environmental causes, human genetics or many of the other major proposed causes for chronic disease, bacteria are driven by a biological imperative, namely the evolutionary impetus to promote their genes through aggressive reproduction. Of course, the same cannot be said for other potential causes, especially human genes. In fact, it's decidedly in the interests of humans not to pass on genes, which limit reproductive fitness, in some cases drastically so.

<html><!– The Vitamin D Receptor (VDR) is at the heart of innate immunity and transcribes thousands of genes.58) Given that the VDR can be inactivated by ligands bacteria are known to create and the fact that 90% of cells in the human body are bacterial, bacteria certainly have the opportunity to cause disease as well.

Some, as a matter of principle, take issue with the MP's “one size fits all” explanation of the pathogenesis of disease. Not to mix metaphors, but bacteria's ability to subvert the VDR is the equivalent of a widespread and easy-to-exploit flaw in a widely distributed operating system for computers. The VDR is evidently quite powerful, by one count coding for over 27,000 human genes59). So, it's not as if humans can evolve itself an alternative in the near term.

Versatile thought it is, the VDR has an enormous vulnerability, one which every species of pathogenic bacteria can take advantage. Can and do software bugs happen on an equivalent scale to that of chronic disease? Absolutely. With scarce resources, why would a group of bacteria engineer an alternate “exploit” if this method for facilitating survival has been working so well for millenia? –></html>

===== Notes and comments =====

  • f127
  • s320a
  • s253
  • Legacy content

Pathogenicity is, in a sense, a highly skilled trade, and only a tiny minority of all the numberless tons of microbes on the earth has ever involved itself in it; most bacteria are busy with their own business, browsing and recycling the rest of life. Indeed, pathogenicity often seems to me a sort of biological accident in which signals are misdirected by the microbe or misinterpreted by the host.—Lewis Thomas, The Medusa and the Snail

Sterile in health

Characteristic of medically important bacteria's outer surface is a rigid cell wall containing peptidoglycan –Review of Medical Microbiology and Immunology, 2008

===== References =====

1)
Zasloff M. Antimicrobial peptides of multicellular organisms. Nature. 2002 Jan 24;415(6870):389-95. doi: 10.1038/415389a.
[PMID: 11807545] [DOI: 10.1038/415389a]
2)
O'Connor SM, Taylor CE, Hughes JM. Emerging infectious determinants of chronic diseases. Emerg Infect Dis. 2006 Jul;12(7):1051-7. doi: 10.3201/eid1207.060037.
[PMID: 16836820] [PMCID: 3291059] [DOI: 10.3201/eid1207.060037]
3)
Siegler RL, Pavia AT, Christofferson RD, Milligan MK. A 20-year population-based study of postdiarrheal hemolytic uremic syndrome in Utah. Pediatrics. 1994 Jul;94(1):35-40.
[PMID: 8008534]
4)
Hahn AF. Guillain-Barré syndrome. Lancet. 1998 Aug 22;352(9128):635-41. doi: 10.1016/S0140-6736(97)12308-X.
[PMID: 9746040] [DOI: 10.1016/S0140-6736(97)12308-X]
5)
Kuroki S, Saida T, Nukina M, Haruta T, Yoshioka M, Kobayashi Y, Nakanishi H. Campylobacter jejuni strains from patients with Guillain-Barré syndrome belong mostly to Penner serogroup 19 and contain beta-N-acetylglucosamine residues. Ann Neurol. 1993 Mar;33(3):243-7. doi: 10.1002/ana.410330304.
[PMID: 8498807] [DOI: 10.1002/ana.410330304]
6)
Hill Gaston JS, Lillicrap MS. Arthritis associated with enteric infection. Best Pract Res Clin Rheumatol. 2003 Apr;17(2):219-39. doi: 10.1016/s1521-6942(02)00104-3.
[PMID: 12787523] [DOI: 10.1016/s1521-6942(02)00104-3]
7)
Brown AS. Prenatal infection as a risk factor for schizophrenia. Schizophr Bull. 2006 Apr;32(2):200-2. doi: 10.1093/schbul/sbj052. Epub 2006 Feb 9.
[PMID: 16469941] [PMCID: 2632220] [DOI: 10.1093/schbul/sbj052]
8)
Decker E, Engelmann G, Findeisen A, Gerner P, Laass M, Ney D, Posovszky C, Hoy L, Hornef MW. Cesarean delivery is associated with celiac disease but not inflammatory bowel disease in children. Pediatrics. 2010 Jun;125(6):e1433-40. doi: 10.1542/peds.2009-2260. Epub 2010 May 17.
[PMID: 20478942] [DOI: 10.1542/peds.2009-2260]
9)
Rossman MD, Kreider ME. Lesson learned from ACCESS (A Case Controlled Etiologic Study of Sarcoidosis). Proc Am Thorac Soc. 2007 Aug 15;4(5):453-6. doi: 10.1513/pats.200607-138MS.
[PMID: 17684288] [DOI: 10.1513/pats.200607-138MS]
10)
Hippisley-Cox J, Pringle M. Are spouses of patients with hypertension at increased risk of having hypertension? A population-based case-control study. Br J Gen Pract. 1998 Sep;48(434):1580-3.
[PMID: 9830183] [PMCID: 1313221]
11)
Daniels JL, Forssen U, Hultman CM, Cnattingius S, Savitz DA, Feychting M, Sparen P. Parental psychiatric disorders associated with autism spectrum disorders in the offspring. Pediatrics. 2008 May;121(5):e1357-62. doi: 10.1542/peds.2007-2296.
[PMID: 18450879] [DOI: 10.1542/peds.2007-2296]
12)
Gribbin J, Hubbard RB, Le Jeune I, Smith CJP, West J, Tata LJ. Incidence and mortality of idiopathic pulmonary fibrosis and sarcoidosis in the UK. Thorax. 2006 Nov;61(11):980-5. doi: 10.1136/thx.2006.062836. Epub 2006 Jul 14.
[PMID: 16844727] [PMCID: 2121155] [DOI: 10.1136/thx.2006.062836]
13)
Kern DG, Neill MA, Wrenn DS, Varone JC. Investigation of a unique time-space cluster of sarcoidosis in firefighters. Am Rev Respir Dis. 1993 Oct;148(4 Pt 1):974-80. doi: 10.1164/ajrccm/148.4_Pt_1.974.
[PMID: 8214953] [DOI: 10.1164/ajrccm/148.4_Pt_1.974]
14)
Goldsmith JR, Herishanu Y, Abarbanel JM, Weinbaum Z. Clustering of Parkinson's disease points to environmental etiology. Arch Environ Health. 1990 Mar-Apr;45(2):88-94. doi: 10.1080/00039896.1990.9935931.
[PMID: 2334236] [DOI: 10.1080/00039896.1990.9935931]
15)
Christakis NA, Fowler JH. The spread of obesity in a large social network over 32 years. N Engl J Med. 2007 Jul 26;357(4):370-9. doi: 10.1056/NEJMsa066082. Epub 2007 Jul 25.
[PMID: 17652652] [DOI: 10.1056/NEJMsa066082]
16)
McCredie M. Cancer epidemiology in migrant populations. Recent Results Cancer Res. 1998;154:298-305. doi: 10.1007/978-3-642-46870-4_21.
[PMID: 10027010] [DOI: 10.1007/978-3-642-46870-4_21]
17)
Parkin DM, Khlat M. Studies of cancer in migrants: rationale and methodology. Eur J Cancer. 1996 May;32A(5):761-71. doi: 10.1016/0959-8049(96)00062-7.
[PMID: 9081351] [DOI: 10.1016/0959-8049(96)00062-7]
18)
Hemminki K, Li X. Cancer risks in second-generation immigrants to Sweden. Int J Cancer. 2002 May 10;99(2):229-37. doi: 10.1002/ijc.10323.
[PMID: 11979438] [DOI: 10.1002/ijc.10323]
19)
Hemminki K, Li X, Czene K. Cancer risks in first-generation immigrants to Sweden. Int J Cancer. 2002 May 10;99(2):218-28. doi: 10.1002/ijc.10322.
[PMID: 11979437] [DOI: 10.1002/ijc.10322]
20)
Hemminki K, Lorenzo Bermejo J, Försti A. The balance between heritable and environmental aetiology of human disease. Nat Rev Genet. 2006 Dec;7(12):958-65. doi: 10.1038/nrg2009.
[PMID: 17139327] [DOI: 10.1038/nrg2009]
21)
Polednak AP. Trends in cancer incidence in Connecticut, 1935-1991. Cancer. 1994 Nov 15;74(10):2863-72. doi: 10.1002/1097-0142(19941115)74:10<2863::aid-cncr2820741020>3.0.co;2-5.
[PMID: 7954249] [DOI: 10.1002/1097-0142(19941115)74:10<2863::aid-cncr2820741020>3.0.co;2-5]
22)
Yiu H, Whittemore AS, Shibata A. Increasing colorectal cancer incidence rates in Japan. Int J Cancer. 2004 May 1;109(5):777-81. doi: 10.1002/ijc.20030.
[PMID: 14999789] [DOI: 10.1002/ijc.20030]
23) , 54)
Ledgerwood LG, Ewald PW, Cochran GM. Genes, germs, and schizophrenia: an evolutionary perspective. Perspect Biol Med. 2003 Summer;46(3):317-48. doi: 10.1353/pbm.2003.0038.
[PMID: 12878806] [DOI: 10.1353/pbm.2003.0038]
24)
Castrogiovanni P, Iapichino S, Pacchierotti C, Pieraccini F. Season of birth in psychiatry. A review. Neuropsychobiology. 1998;37(4):175-81. doi: 10.1159/000026499.
[PMID: 9648124] [DOI: 10.1159/000026499]
25)
Parker G, Mahendran R, Koh ES, Machin D. Season of birth in schizophrenia: no latitude at the equator. Br J Psychiatry. 2000 Jan;176:68-71. doi: 10.1192/bjp.176.1.68.
[PMID: 10789330] [DOI: 10.1192/bjp.176.1.68]
26)
Krassas GE, Tziomalos K, Pontikides N, Lewy H, Laron Z. Seasonality of month of birth of patients with Graves' and Hashimoto's diseases differ from that in the general population. Eur J Endocrinol. 2007 Jun;156(6):631-6. doi: 10.1530/EJE-07-0015.
[PMID: 17535862] [DOI: 10.1530/EJE-07-0015]
27)
Fredricks DN, Relman DA. Infectious agents and the etiology of chronic idiopathic diseases. Curr Clin Top Infect Dis. 1998;18:180-200.
[PMID: 9779355]
28)
Cosma CL, Sherman DR, Ramakrishnan L. The secret lives of the pathogenic mycobacteria. Annu Rev Microbiol. 2003;57:641-76. doi: 10.1146/annurev.micro.57.030502.091033.
[PMID: 14527294] [DOI: 10.1146/annurev.micro.57.030502.091033]
29)
Iio K, Iio TU, Okui Y, Ichikawa H, Tanimoto Y, Miyahara N, Kanehiro A, Tanimoto M, Nakata Y, Kataoka M. Experimental pulmonary granuloma mimicking sarcoidosis induced by Propionibacterium acnes in mice. Acta Med Okayama. 2010 Apr;64(2):75-83. doi: 10.18926/AMO/32852.
[PMID: 20424662] [DOI: 10.18926/AMO/32852]
30)
Parracho HM, Bingham MO, Gibson GR, McCartney AL. Differences between the gut microflora of children with autistic spectrum disorders and that of healthy children. J Med Microbiol. 2005 Oct;54(Pt 10):987-991. doi: 10.1099/jmm.0.46101-0.
[PMID: 16157555] [DOI: 10.1099/jmm.0.46101-0]
31)
Martirosian G. [Anaerobic intestinal microflora in pathogenesis of autism?]. Postepy Hig Med Dosw (Online). 2004;58:349-51.
[PMID: 15459553]
32)
Kalliomäki M, Collado MC, Salminen S, Isolauri E. Early differences in fecal microbiota composition in children may predict overweight. Am J Clin Nutr. 2008 Mar;87(3):534-8. doi: 10.1093/ajcn/87.3.534.
[PMID: 18326589] [DOI: 10.1093/ajcn/87.3.534]
33)
Ley RE, Bäckhed F, Turnbaugh P, Lozupone CA, Knight RD, Gordon JI. Obesity alters gut microbial ecology. Proc Natl Acad Sci U S A. 2005 Aug 2;102(31):11070-5. doi: 10.1073/pnas.0504978102. Epub 2005 Jul 20.
[PMID: 16033867] [PMCID: 1176910] [DOI: 10.1073/pnas.0504978102]
34)
Ley RE, Turnbaugh PJ, Klein S, Gordon JI. Microbial ecology: human gut microbes associated with obesity. Nature. 2006 Dec 21;444(7122):1022-3. doi: 10.1038/4441022a.
[PMID: 17183309] [DOI: 10.1038/4441022a]
35)
Turnbaugh PJ, Ley RE, Mahowald MA, Magrini V, Mardis ER, Gordon JI. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature. 2006 Dec 21;444(7122):1027-31. doi: 10.1038/nature05414.
[PMID: 17183312] [DOI: 10.1038/nature05414]
36)
Nicolson GL, Gan R, Nicolson NL, Haier J. Evidence for Mycoplasma ssp., Chlamydia pneunomiae, and human herpes virus-6 coinfections in the blood of patients with autistic spectrum disorders. J Neurosci Res. 2007 Apr;85(5):1143-8. doi: 10.1002/jnr.21203.
[PMID: 17265454] [DOI: 10.1002/jnr.21203]
37)
Caballero B, Clay T, Davis SM, Ethelbah B, Rock BH, Lohman T, Norman J, Story M, Stone EJ, Stephenson L, Stevens J, Pathways Study Research Group. Pathways: a school-based, randomized controlled trial for the prevention of obesity in American Indian schoolchildren. Am J Clin Nutr. 2003 Nov;78(5):1030-8. doi: 10.1093/ajcn/78.5.1030.
[PMID: 14594792] [PMCID: 4863237] [DOI: 10.1093/ajcn/78.5.1030]
38)
Reilly JJ, Kelly L, Montgomery C, Williamson A, Fisher A, McColl JH, Lo Conte R, Paton JY, Grant S. Physical activity to prevent obesity in young children: cluster randomised controlled trial. BMJ. 2006 Nov 18;333(7577):1041. doi: 10.1136/bmj.38979.623773.55. Epub 2006 Oct 6.
[PMID: 17028105] [PMCID: 1647320] [DOI: 10.1136/bmj.38979.623773.55]
39)
Padilla ML, Schilero GJ, Teirstein AS. Donor-acquired sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis. 2002 Mar;19(1):18-24.
[PMID: 12002380]
40)
Heyll A, Meckenstock G, Aul C, Söhngen D, Borchard F, Hadding U, Mödder U, Leschke M, Schneider W. Possible transmission of sarcoidosis via allogeneic bone marrow transplantation. Bone Marrow Transplant. 1994 Jul;14(1):161-4.
[PMID: 7951107]
41)
Sundar KM, Carveth HJ, Gosselin MV, Beatty PG, Colby TV, Hoidal JR. Granulomatous pneumonitis following bone marrow transplantation. Bone Marrow Transplant. 2001 Sep;28(6):627-30. doi: 10.1038/sj.bmt.1703192.
[PMID: 11607780] [DOI: 10.1038/sj.bmt.1703192]
42)
Kluger N, Phan A, Debarbieux S, Balme B, Thomas L. Skin cancers arising in tattoos: coincidental or not?. Dermatology. 2008;217(3):219-21. doi: 10.1159/000143794. Epub 2008 Jul 10.
[PMID: 18617744] [DOI: 10.1159/000143794]
43)
Antonovich DD, Callen JP. Development of sarcoidosis in cosmetic tattoos. Arch Dermatol. 2005 Jul;141(7):869-72. doi: 10.1001/archderm.141.7.869.
[PMID: 16027303] [DOI: 10.1001/archderm.141.7.869]
44)
Selim A, Ehrsam E, Atassi MB, Khachemoune A. Scar sarcoidosis: a case report and brief review. Cutis. 2006 Dec;78(6):418-22.
[PMID: 17243430]
45)
de Almeida HL, Fiss RC. Scar sarcoidosis with a 50-year interval between an accident and onset of lesions. Dermatol Online J. 2008 Nov 15;14(11):18.
[PMID: 19094856]
46)
Sorabjee JS, Garje R. Reactivation of old scars: inevitably sarcoid. Postgrad Med J. 2005 Jan;81(951):60-1. doi: 10.1136/pgmj.2004.018796.
[PMID: 15640432] [PMCID: 1743183] [DOI: 10.1136/pgmj.2004.018796]
47)
Corazza M, Bacilieri S, Strumìa R. Post-herpes zoster scar sarcoidosis. Acta Derm Venereol. 1999 Jan;79(1):95. doi: 10.1080/000155599750011903.
[PMID: 10086879] [DOI: 10.1080/000155599750011903]
48)
Alabi GO, George AO. Cutaneous sarcoidosis and tribal scarifications in West Africa. Int J Dermatol. 1989 Jan-Feb;28(1):29-31. doi: 10.1111/j.1365-4362.1989.tb01305.x.
[PMID: 2917808] [DOI: 10.1111/j.1365-4362.1989.tb01305.x]
49)
Healsmith MF, Hutchinson PE. The development of scar sarcoidosis at the site of desensitization injections. Clin Exp Dermatol. 1992 Sep;17(5):369-70. doi: 10.1111/j.1365-2230.1992.tb00236.x.
[PMID: 1458650] [DOI: 10.1111/j.1365-2230.1992.tb00236.x]
50)
Ames BN, Gold LS. The causes and prevention of cancer: gaining perspective. Environ Health Perspect. 1997 Jun;105 Suppl 4(Suppl 4):865-73. doi: 10.1289/ehp.97105s4865.
[PMID: 9255573] [PMCID: 1470059] [DOI: 10.1289/ehp.97105s4865]
51)
Lunn RM, Zhang YJ, Wang LY, Chen CJ, Lee PH, Lee CS, Tsai WY, Santella RM. p53 mutations, chronic hepatitis B virus infection, and aflatoxin exposure in hepatocellular carcinoma in Taiwan. Cancer Res. 1997 Aug 15;57(16):3471-7.
[PMID: 9270015]
52)
Cochran GM, Ewald PW, Cochran KD. Infectious causation of disease: an evolutionary perspective. Perspect Biol Med. 2000 Spring;43(3):406-48. doi: 10.1353/pbm.2000.0016.
[PMID: 10893730] [DOI: 10.1353/pbm.2000.0016]
53)
Ewald PW, Cochran GM. Chlamydia pneumoniae and cardiovascular disease: an evolutionary perspective on infectious causation and antibiotic treatment. J Infect Dis. 2000 Jun;181 Suppl 3:S394-401. doi: 10.1086/315602.
[PMID: 10839723] [DOI: 10.1086/315602]
55)
Osby U, Correia N, Brandt L, Ekbom A, Sparén P. Mortality and causes of death in schizophrenia in Stockholm county, Sweden. Schizophr Res. 2000 Sep 29;45(1-2):21-8. doi: 10.1016/s0920-9964(99)00191-7.
[PMID: 10978869] [DOI: 10.1016/s0920-9964(99)00191-7]
56)
Bassett AS, Bury A, Hodgkinson KA, Honer WG. Reproductive fitness in familial schizophrenia. Schizophr Res. 1996 Sep 18;21(3):151-60. doi: 10.1016/0920-9964(96)00018-7.
[PMID: 8885043] [PMCID: 3161954] [DOI: 10.1016/0920-9964(96)00018-7]
57)
Bennedsen BE, Mortensen PB, Olesen AV, Henriksen TB. Congenital malformations, stillbirths, and infant deaths among children of women with schizophrenia. Arch Gen Psychiatry. 2001 Jul;58(7):674-9. doi: 10.1001/archpsyc.58.7.674.
[PMID: 11448375] [DOI: 10.1001/archpsyc.58.7.674]
58) , 59)
Wang T, Tavera-Mendoza LE, Laperriere D, Libby E, MacLeod NB, Nagai Y, Bourdeau V, Konstorum A, Lallemant B, Zhang R, Mader S, White JH. Large-scale in silico and microarray-based identification of direct 1,25-dihydroxyvitamin D3 target genes. Mol Endocrinol. 2005 Nov;19(11):2685-95. doi: 10.1210/me.2005-0106. Epub 2005 Jul 7.
[PMID: 16002434] [DOI: 10.1210/me.2005-0106]